Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:18 PM
Ignite Modification Date:
2025-12-24 @ 11:18 PM
NCT ID:
NCT06985056
Eligibility Criteria:
Inclusion Criteria:
* patients ≥ 18 years with malignant melanoma (Stage IIb - IV) receiving adjuvant immuno- or targeted therapy
* patients already on the same treatment protocol for at least 3 months
* sufficient knowledge of German
* completed and signed written consent form and completed medical history form
* medical clearance for the exercise program and performance diagnostics
* ability to participate in the exercise program
* willingness to visit the study hospital for training sessions and examinations
Exclusion Criteria:
* confirmation of contraindications for physical exercise by the attending physician (e.g. fracture risk in the case of bone metastases)
* untreated, symptomatic, known brain metastases
* severe neurological or cardiac impairment according to ACSM criteria
* confirmation of respiratory insufficiency by the attending physician
* life expectancy less than 3 months
* physical or mental conditions that would not allow implementation of the exercise program or study protocol
* excessive physical activity (i.e. \>150 minutes/week of moderate to intense physical activity and systematic intense strength/endurance training at least twice a week for one hour)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06985056
Study Brief:
Protocol Section:
NCT06985056